Search results
Childhood eczema could be treated by tailored vaccine: study
WFMZ Eastern Pennsylvania and Western New Jersey· 6 days agoResearchers at Trinity College Dublin believe the jab may be key to treating bacteria-driven...
Aclaris Therapeutics, Inc. (NASDAQ:ACRS) Q1 2024 Earnings Call Transcript
Insider Monkey via Yahoo Finance· 6 days agoAclaris Therapeutics, Inc. (NASDAQ:ACRS) Q1 2024 Earnings Call Transcript May 7, 2024 Aclaris...
Jefferies raises Nektar Therapeutics stock target, maintains hold By Investing.com
Investing.com· 4 days agoThe adjustment comes as Nektar Therapeutics progresses with its clinical trials. The company is...
The UK's most unhygienic habits, from sharing towels to not washing hands
Yahoo Life UK· 11 hours ago"Sharing towels between family members can be dangerous as certain skin pathogens can be introduced...
Understanding Rosacea: 10 Natural Ways to Soothe and Calm Red, Irritated Skin
Best Life· 6 days agoRosacea is an inflammatory skin condition that can cause a range of uncomfortable symptoms. Many...
BofA bullish on Apogee stock, sees significant market growth potential By Investing.com
Investing.com· 4 days agoFriday, BofA Securities initiated coverage on Apogee (NASDAQ:APOG) Therapeutics Inc (NASDAQ:APGE)...
RAPT Therapeutics Shares Hit 52-Week Low After Trials Closed
Morningstar· 5 days agoThe immunology-based therapeutics company said it has decided to close and unblind both its Phase 2b clinical trial of zelnecirnon in atopic dermatitis ...
Earnings Superstars: 3 Stocks Primed to Outperform This Quarter
InvestorPlace via Yahoo Finance· 6 days agoCompanies have generally managed to perform well against the consensus of earnings forecasts, with...
Sanofi (SNY), Regeneron's Dupixent sBLA Gets FDA Priority Tag
Zacks via Yahoo Finance· 1 day agoSanofi (SNY) and Regeneron's (REGN) Dupixent is poised to be the first medicine for adolescents with...
What's Going On With Dermatitis-Focused RAPT Therapeutics Stock On Thursday?
Benzinga via Yahoo Finance· 5 days agoOn Thursday, RAPT Therapeutics Inc. (NASDAQ:RAPT) announced that it has decided to close and unblind...